Three of the most common actionable driver oncogenes in NSCLC are epidermal growth factor receptor (EGFR), anaplastic lymphoma kinase (ALK), and rat sarcoma virus (RAS) [4]. This evidence concerns the gene ALK and non-small cell lung carcinoma.